The FDA has released finalized guidance on the distribution of IVD products. IVD products for the lab research phase of development may be commercialized if they are labeled, “For Research Use Only [RUO]. Not for use in diagnostic procedures.” Investigational devices shipped for testing prior to commercial marketing must be labeled, “For Investigational Use Only […]
The International Energy Agency (IEA) stated that Middle East producers’ delay in new oil production investments could lead to higher oil prices due to supply shortages. Although it forecasts the US to become the largest producer of oil worldwide by 2015, the IEA expects US production to decline after 2020. Some Middle Eastern nations have […]
Worldwide expenditures on medicines is forecast to increase 3%–6% between 2013 and 2017 to $1,170–$1,200 billion, excluding off-invoice discounts and rebates. Spending in developed countries is estimated to grow 1%–4% to $650–$680 billion. Spending in pharmerging markets will increase 10%–13% to $370–$400 billion, with spending in China estimated to grow 14%–17% to $160–$190 billion. Spending […]
Paris and Codolet, France 11/18/13; Louvain-la-Neuve, Belgium 11/18/13—Drug discovery and IVD assay developer and service provider Cisbio Bioassays has been sold by Ion Beam Applications to private equity firm Argos Soditic and management for €16.3 million ($22.0 million = €0.74 = $1). Based in Codolet, France, with annual revenues of €35 million ($47 million), Cisbio […]
Conshohocken, PA 11/22/13; London, UK 11/22/13—Instem, a publicly held supplier of IT solutions to the early development health care market, has acquired Perceptive Instruments for £1.0 million ($1.6 million = £0.62 = $1). Perceptive develops, manufactures and supplies image analysis and data processing solutions primarily focused on toxicology, microbiology and immunology. The UK-based firm had […]
Graz, Austria 11/18/13—High precision instrument firm Anton Paar has acquired CSM Instruments for an undisclosed amount. Based in Switzerland, CSM develops, produces and markets laboratory instruments for the characterization of mechanical properties on material surfaces at the micro- and nano-scales. The company generated sales of €12 million ($15 million = €0.78 = $1) in 2012 […]
Waltham, MA 11/26/13; Brussels, Belgium 11/26/13—The European Commission (EC) has cleared the merger of Thermo Fisher Scientific and Life Technologies (see IBO 4/15/13) with conditions. The EC found that the merger risked reduced competition in the European Economic Area with respect to the production and supply of media and sera for cell culture, gene silencing […]
Along with its 2013 Scoreboard, the EU also published a survey of industrial R&D trends. The survey is based on responses from 172 EU Scoreboard companies, which collectively spend €62 billion ($79 billion = €0.78 = $1) on R&D. The respondents expect their R&D expenditures to increase an average of 2.6% from 2013 to 2015. […]
Pay Invoice
Latest Blogs
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
